The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
- Status
- COMPLETED
- Phase
- N/A
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure
- Status
- UNKNOWN
- Phase
- PHASE2
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
- Status
- COMPLETED
- Phase
- NA
An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Prevalence of EGFR Mutations in Participants With NSCLC
- Status
- COMPLETED
- Phase
- N/A
Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)
- Status
- COMPLETED
- Phase
- N/A